Dimed SA Distribuidora de Medicamentos
BOVESPA:PNVL3

Watchlist Manager
Dimed SA Distribuidora de Medicamentos Logo
Dimed SA Distribuidora de Medicamentos
BOVESPA:PNVL3
Watchlist
Price: 9.58 BRL 0.31% Market Closed
Market Cap: 1.4B BRL
Have any thoughts about
Dimed SA Distribuidora de Medicamentos?
Write Note

Intrinsic Value

The intrinsic value of one PNVL3 stock under the Base Case scenario is 16.71 BRL. Compared to the current market price of 9.58 BRL, Dimed SA Distribuidora de Medicamentos is Undervalued by 43%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

PNVL3 Intrinsic Value
16.71 BRL
Undervaluation 43%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation Backtest
Dimed SA Distribuidora de Medicamentos

Backtest Intrinsic Value
Dive into the past to invest in the future

Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start backtest now and learn if your stock is truly undervalued or overvalued!

Run Backtest
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
Register to View Results
Register to View Results

To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.

Backtest Unavailable

The backtest for PNVL3 cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.

Backtest In Progress...
Backtest In Progress...
How do you feel about PNVL3?
Bearish
Neutral
Bullish

Fundamental Analysis

Economic Moat
Dimed SA Distribuidora de Medicamentos

Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

Investment Journal
AI Assistant
AI Assistant
Ask me anything about Dimed SA Distribuidora de Medicamentos

Provide an overview of the primary business activities
of Dimed SA Distribuidora de Medicamentos.

What unique competitive advantages
does Dimed SA Distribuidora de Medicamentos hold over its rivals?

What risks and challenges
does Dimed SA Distribuidora de Medicamentos face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Dimed SA Distribuidora de Medicamentos.

Provide P/S
for Dimed SA Distribuidora de Medicamentos.

Provide P/E
for Dimed SA Distribuidora de Medicamentos.

Provide P/OCF
for Dimed SA Distribuidora de Medicamentos.

Provide P/FCFE
for Dimed SA Distribuidora de Medicamentos.

Provide P/B
for Dimed SA Distribuidora de Medicamentos.

Provide EV/S
for Dimed SA Distribuidora de Medicamentos.

Provide EV/GP
for Dimed SA Distribuidora de Medicamentos.

Provide EV/EBITDA
for Dimed SA Distribuidora de Medicamentos.

Provide EV/EBIT
for Dimed SA Distribuidora de Medicamentos.

Provide EV/OCF
for Dimed SA Distribuidora de Medicamentos.

Provide EV/FCFF
for Dimed SA Distribuidora de Medicamentos.

Provide EV/IC
for Dimed SA Distribuidora de Medicamentos.

Show me price targets
for Dimed SA Distribuidora de Medicamentos made by professional analysts.

What are the Revenue projections
for Dimed SA Distribuidora de Medicamentos?

How accurate were the past Revenue estimates
for Dimed SA Distribuidora de Medicamentos?

What are the Net Income projections
for Dimed SA Distribuidora de Medicamentos?

How accurate were the past Net Income estimates
for Dimed SA Distribuidora de Medicamentos?

What are the EPS projections
for Dimed SA Distribuidora de Medicamentos?

How accurate were the past EPS estimates
for Dimed SA Distribuidora de Medicamentos?

What are the EBIT projections
for Dimed SA Distribuidora de Medicamentos?

How accurate were the past EBIT estimates
for Dimed SA Distribuidora de Medicamentos?

Compare the revenue forecasts
for Dimed SA Distribuidora de Medicamentos with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Dimed SA Distribuidora de Medicamentos and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Dimed SA Distribuidora de Medicamentos against its competitors.

Analyze the profit margins
(gross, operating, and net) of Dimed SA Distribuidora de Medicamentos compared to its peers.

Compare the P/E ratios
of Dimed SA Distribuidora de Medicamentos against its peers.

Discuss the investment returns and shareholder value creation
comparing Dimed SA Distribuidora de Medicamentos with its peers.

Analyze the financial leverage
of Dimed SA Distribuidora de Medicamentos compared to its main competitors.

Show all profitability ratios
for Dimed SA Distribuidora de Medicamentos.

Provide ROE
for Dimed SA Distribuidora de Medicamentos.

Provide ROA
for Dimed SA Distribuidora de Medicamentos.

Provide ROIC
for Dimed SA Distribuidora de Medicamentos.

Provide ROCE
for Dimed SA Distribuidora de Medicamentos.

Provide Gross Margin
for Dimed SA Distribuidora de Medicamentos.

Provide Operating Margin
for Dimed SA Distribuidora de Medicamentos.

Provide Net Margin
for Dimed SA Distribuidora de Medicamentos.

Provide FCF Margin
for Dimed SA Distribuidora de Medicamentos.

Show all solvency ratios
for Dimed SA Distribuidora de Medicamentos.

Provide D/E Ratio
for Dimed SA Distribuidora de Medicamentos.

Provide D/A Ratio
for Dimed SA Distribuidora de Medicamentos.

Provide Interest Coverage Ratio
for Dimed SA Distribuidora de Medicamentos.

Provide Altman Z-Score Ratio
for Dimed SA Distribuidora de Medicamentos.

Provide Quick Ratio
for Dimed SA Distribuidora de Medicamentos.

Provide Current Ratio
for Dimed SA Distribuidora de Medicamentos.

Provide Cash Ratio
for Dimed SA Distribuidora de Medicamentos.

What is the historical Revenue growth
over the last 5 years for Dimed SA Distribuidora de Medicamentos?

What is the historical Net Income growth
over the last 5 years for Dimed SA Distribuidora de Medicamentos?

What is the current Free Cash Flow
of Dimed SA Distribuidora de Medicamentos?

Discuss the annual earnings per share (EPS)
trend over the past five years for Dimed SA Distribuidora de Medicamentos.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Dimed SA Distribuidora de Medicamentos

Current Assets 1.9B
Cash & Short-Term Investments 270.6m
Receivables 556.3m
Other Current Assets 1.1B
Non-Current Assets 1.3B
PP&E 1.1B
Intangibles 89.3m
Other Non-Current Assets 88.6m
Current Liabilities 1.2B
Accounts Payable 559.4m
Accrued Liabilities 174.7m
Other Current Liabilities 459.2m
Non-Current Liabilities 781.8m
Long-Term Debt 766.6m
Other Non-Current Liabilities 15.2m
Efficiency

Earnings Waterfall
Dimed SA Distribuidora de Medicamentos

Revenue
4.7B BRL
Cost of Revenue
-3.2B BRL
Gross Profit
1.5B BRL
Operating Expenses
-1.3B BRL
Operating Income
159.9m BRL
Other Expenses
-68.6m BRL
Net Income
91.3m BRL

Free Cash Flow Analysis
Dimed SA Distribuidora de Medicamentos

Last Value
3-Years Average
FCF Margin
Conversion Rate
Fundamental Scores

PNVL3 Profitability Score
Profitability Due Diligence

Dimed SA Distribuidora de Medicamentos's profitability score is 50/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Positive 3-Years Revenue Growth
Positive Revenue Growth Forecast
Positive 1-Year Revenue Growth
50/100
Profitability
Score

Dimed SA Distribuidora de Medicamentos's profitability score is 50/100. The higher the profitability score, the more profitable the company is.

PNVL3 Solvency Score
Solvency Due Diligence

Dimed SA Distribuidora de Medicamentos's solvency score is 52/100. The higher the solvency score, the more solvent the company is.

Low D/E
Long-Term Solvency
Short-Term Solvency
Average Altman Z-Score
52/100
Solvency
Score

Dimed SA Distribuidora de Medicamentos's solvency score is 52/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

PNVL3 Price Targets Summary
Dimed SA Distribuidora de Medicamentos

Wall Street analysts forecast PNVL3 stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for PNVL3 is 14.28 BRL with a low forecast of 13.13 BRL and a high forecast of 15.75 BRL.

Lowest
Price Target
13.13 BRL
37% Upside
Average
Price Target
14.28 BRL
49% Upside
Highest
Price Target
15.75 BRL
64% Upside
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for PNVL3?

Click here to dive deeper.

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for PNVL3 is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Profile

Dimed SA Distribuidora de Medicamentos Logo
Dimed SA Distribuidora de Medicamentos

Country

Brazil

Industry

Retail

Market Cap

1.4B BRL

Dividend Yield

4.57%

Description

Dimed SA Distribuidora de Medicamentos engages in the marketing, distribution and sale of medicines and cosmetics. The company is headquartered in Eldorado Do Sul, Rio Grande Do Sul and currently employs 9,414 full-time employees. The Company, along with its subsidiaries, sells, distributes, imports, exports and produces a variety of products, including drugs, perfumes, cosmetics, dermo-cosmetics, personal care products, dietary supplements, and fitness, orthopedic and physiotherapy accessories. The company organizes its business into two main segments: Medicine and Perfumery. The firm provides retail and wholesale distribution. The firm owns distribution centers in Brazilian states of Rio Grande do Sul, Santa Catarina, Parana, Goias and Espirito Santo, as well as over 280 stores in states of Rio Grande do Sul, Santa Catarina and Parana.

Contact

RIO GRANDE DO SUL
Eldorado do Sul
Avenida Industrial Belgraff, 865, Predio 100, Industrial
+555134819677
www.panvel.com.br

IPO

1992-10-29

Employees

9 414

Officers

Chief Executive Officer
Mr. Julio Ricardo Mottin Neto Neto
CFO & Investor Relations Officer
Mr. AntĂ´nio Carlos Tocchetto Napp
Executive Officer, MD & Director
Mr. Roberto Coimbra Santos
Controller
Sergio Rigon

See Also

Discover More
What is the Intrinsic Value of one PNVL3 stock?

The intrinsic value of one PNVL3 stock under the Base Case scenario is 16.71 BRL.

Is PNVL3 stock undervalued or overvalued?

Compared to the current market price of 9.58 BRL, Dimed SA Distribuidora de Medicamentos is Undervalued by 43%.

Back to Top